2002
Factors Associated with HIV Seroprevalence among Participants Enrolling at a Needle Exchange Program
Vertefeuille J, Strathdee S, Huettner S, Brown M, Vlahov D. Factors Associated with HIV Seroprevalence among Participants Enrolling at a Needle Exchange Program. Journal Of Drug Issues 2002, 32: 1125-1138. DOI: 10.1177/002204260203200408.Peer-Reviewed Original ResearchInjection drug usersHIV seroprevalenceHIV-seronegative counterpartsHIV-seropositive individualsHIV risk factorsDaily cocaine injectionsDaily heroin injectionDrug use characteristicsHarms of drugsHIV seropositive statusNeedle exchange programsLogistic regression modelsSpeedball injectionHIV antibodiesHIV infectionHeroin injectionProspective studyRisk factorsCocaine injectionFactors AssociatedDrug usersMultivariate modelProgram entryHIVSeroprevalence
2000
Decline in Self-Reported High-Risk Injection-Related Behaviors Among HIV-Seropositive Participants in the Baltimore Needle Exchange Program
Vertefeuille J, Marx M, Tun W, Huettner S, Strathdee S, Vlahov D. Decline in Self-Reported High-Risk Injection-Related Behaviors Among HIV-Seropositive Participants in the Baltimore Needle Exchange Program. AIDS And Behavior 2000, 4: 381-388. DOI: 10.1023/a:1026406623736.Peer-Reviewed Original ResearchNeedle exchange programsHIV-seropositive drug usersDrug usersRisky drug use behaviorsHigh-risk injection practicesInjection-related behaviorsHIV-seropositive individualsHIV-seropositive participantsBaltimore Needle Exchange ProgramDrug use behaviorsNEP participantsDrug treatmentInjection practicesNEP attendanceMean numberVisitsT-testSignificant reductionExchange programsBaselineChi-square statisticsInjectionSyringesParticipantsFollow
1992
Immune Serum Markers and CD4 Cell Counts in HIV-Infected Intravenous Drug Users.
Chaisson R, Taylor E, Margolick J, Muñoz A, Solomon L, Cohn S, Nelson K, Vlahov D. Immune Serum Markers and CD4 Cell Counts in HIV-Infected Intravenous Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1992, 5: 456. PMID: 1348535, DOI: 10.1097/00126334-199205000-00004.Peer-Reviewed Original ResearchConceptsCD4 cell countSerum immune markersDrug use patternsCell countCD4 countHIV statusImmune markersImmune activationDrug usersHuman immunodeficiency virus (HIV) infectionHIV-seropositive individualsImmunodeficiency virus infectionSerum IgA levelsIntravenous drug usersAssociation of raceIgA levelsNeopterin levelsSerum markersVirus infectionLarge cohortBacterial infectionsHIVHepatitisInfectionMarkers